Medication exposure in pregnancy risk evaluation program: The prevalence of asthma medication use during pregnancy

Craig Anthony Hansen, Peter Joski, Heather Freiman, Susan Andrade, Sengwee Toh, Sascha Dublin, Craig Cheetham, William Cooper, Pamala Pawloski, De Kun Li, Sarah Beaton, Sigal Kaplan, Pamela Scott, Tarek Hammad, Robert Davis

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Asthma is one of the most common chronic diseases in women of reproductive age, occurring in up to 8 % of pregnancies. The objective of this study is to assess the prevalence of asthma medication use during pregnancy in a large diverse cohort. We identified women aged 15-45 years who delivered a live born infant between 2001 and 2007 across 11 U.S. health plans within the Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP). Using health plans' administrative and claims data, and birth certificate data, we identified deliveries for which women filled asthma medications from 90 days before pregnancy through delivery. Prevalence (%) was calculated for asthma diagnosis and medication dispensing. There were 586,276 infants from 575,632 eligible deliveries in the MEPREP cohort. Asthma prevalence among mothers was 6.7 %, increasing from 5.5 % in 2001 to 7.8 % in 2007. A total of 9.7 % (n = 55,914) of women were dispensed asthma medications during pregnancy. The overall prevalence of maintenance-only medication, rescue-only medication, and combined maintenance and rescue medication was 0.6, 6.7, and 2.4 % respectively. The prevalence of maintenance-only use doubled during the study period from 0.4 to 0.8 %, while rescue-only use decreased from 7.4 to 5.8 %. In this large population-based pregnancy cohort, the prevalence of asthma diagnoses increased over time. The dispensing of maintenance-only medication increased over time, while rescue-only medication dispensing decreased over time.

LanguageEnglish
Pages1611-1621
Number of pages11
JournalMaternal and Child Health Journal
Volume17
Issue number9
DOIs
Publication statusPublished - 1 Nov 2013

Keywords

  • Asthma
  • Medication
  • Pregnancy
  • Prevalence

ASJC Scopus subject areas

  • Epidemiology
  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology
  • Public Health, Environmental and Occupational Health

Cite this

Hansen, Craig Anthony ; Joski, Peter ; Freiman, Heather ; Andrade, Susan ; Toh, Sengwee ; Dublin, Sascha ; Cheetham, Craig ; Cooper, William ; Pawloski, Pamala ; Li, De Kun ; Beaton, Sarah ; Kaplan, Sigal ; Scott, Pamela ; Hammad, Tarek ; Davis, Robert. / Medication exposure in pregnancy risk evaluation program : The prevalence of asthma medication use during pregnancy. In: Maternal and Child Health Journal. 2013 ; Vol. 17, No. 9. pp. 1611-1621.
@article{94f45181ac004c88a866de2b8e691ec6,
title = "Medication exposure in pregnancy risk evaluation program: The prevalence of asthma medication use during pregnancy",
abstract = "Asthma is one of the most common chronic diseases in women of reproductive age, occurring in up to 8 {\%} of pregnancies. The objective of this study is to assess the prevalence of asthma medication use during pregnancy in a large diverse cohort. We identified women aged 15-45 years who delivered a live born infant between 2001 and 2007 across 11 U.S. health plans within the Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP). Using health plans' administrative and claims data, and birth certificate data, we identified deliveries for which women filled asthma medications from 90 days before pregnancy through delivery. Prevalence ({\%}) was calculated for asthma diagnosis and medication dispensing. There were 586,276 infants from 575,632 eligible deliveries in the MEPREP cohort. Asthma prevalence among mothers was 6.7 {\%}, increasing from 5.5 {\%} in 2001 to 7.8 {\%} in 2007. A total of 9.7 {\%} (n = 55,914) of women were dispensed asthma medications during pregnancy. The overall prevalence of maintenance-only medication, rescue-only medication, and combined maintenance and rescue medication was 0.6, 6.7, and 2.4 {\%} respectively. The prevalence of maintenance-only use doubled during the study period from 0.4 to 0.8 {\%}, while rescue-only use decreased from 7.4 to 5.8 {\%}. In this large population-based pregnancy cohort, the prevalence of asthma diagnoses increased over time. The dispensing of maintenance-only medication increased over time, while rescue-only medication dispensing decreased over time.",
keywords = "Asthma, Medication, Pregnancy, Prevalence",
author = "Hansen, {Craig Anthony} and Peter Joski and Heather Freiman and Susan Andrade and Sengwee Toh and Sascha Dublin and Craig Cheetham and William Cooper and Pamala Pawloski and Li, {De Kun} and Sarah Beaton and Sigal Kaplan and Pamela Scott and Tarek Hammad and Robert Davis",
year = "2013",
month = "11",
day = "1",
doi = "10.1007/s10995-012-1173-x",
language = "English",
volume = "17",
pages = "1611--1621",
journal = "Maternal and Child Health Journal",
issn = "1092-7875",
publisher = "Springer GmbH & Co, Auslieferungs-Gesellschaf",
number = "9",

}

Hansen, CA, Joski, P, Freiman, H, Andrade, S, Toh, S, Dublin, S, Cheetham, C, Cooper, W, Pawloski, P, Li, DK, Beaton, S, Kaplan, S, Scott, P, Hammad, T & Davis, R 2013, 'Medication exposure in pregnancy risk evaluation program: The prevalence of asthma medication use during pregnancy', Maternal and Child Health Journal, vol. 17, no. 9, pp. 1611-1621. https://doi.org/10.1007/s10995-012-1173-x

Medication exposure in pregnancy risk evaluation program : The prevalence of asthma medication use during pregnancy. / Hansen, Craig Anthony; Joski, Peter; Freiman, Heather; Andrade, Susan; Toh, Sengwee; Dublin, Sascha; Cheetham, Craig; Cooper, William; Pawloski, Pamala; Li, De Kun; Beaton, Sarah; Kaplan, Sigal; Scott, Pamela; Hammad, Tarek; Davis, Robert.

In: Maternal and Child Health Journal, Vol. 17, No. 9, 01.11.2013, p. 1611-1621.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Medication exposure in pregnancy risk evaluation program

T2 - Maternal and Child Health Journal

AU - Hansen, Craig Anthony

AU - Joski, Peter

AU - Freiman, Heather

AU - Andrade, Susan

AU - Toh, Sengwee

AU - Dublin, Sascha

AU - Cheetham, Craig

AU - Cooper, William

AU - Pawloski, Pamala

AU - Li, De Kun

AU - Beaton, Sarah

AU - Kaplan, Sigal

AU - Scott, Pamela

AU - Hammad, Tarek

AU - Davis, Robert

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Asthma is one of the most common chronic diseases in women of reproductive age, occurring in up to 8 % of pregnancies. The objective of this study is to assess the prevalence of asthma medication use during pregnancy in a large diverse cohort. We identified women aged 15-45 years who delivered a live born infant between 2001 and 2007 across 11 U.S. health plans within the Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP). Using health plans' administrative and claims data, and birth certificate data, we identified deliveries for which women filled asthma medications from 90 days before pregnancy through delivery. Prevalence (%) was calculated for asthma diagnosis and medication dispensing. There were 586,276 infants from 575,632 eligible deliveries in the MEPREP cohort. Asthma prevalence among mothers was 6.7 %, increasing from 5.5 % in 2001 to 7.8 % in 2007. A total of 9.7 % (n = 55,914) of women were dispensed asthma medications during pregnancy. The overall prevalence of maintenance-only medication, rescue-only medication, and combined maintenance and rescue medication was 0.6, 6.7, and 2.4 % respectively. The prevalence of maintenance-only use doubled during the study period from 0.4 to 0.8 %, while rescue-only use decreased from 7.4 to 5.8 %. In this large population-based pregnancy cohort, the prevalence of asthma diagnoses increased over time. The dispensing of maintenance-only medication increased over time, while rescue-only medication dispensing decreased over time.

AB - Asthma is one of the most common chronic diseases in women of reproductive age, occurring in up to 8 % of pregnancies. The objective of this study is to assess the prevalence of asthma medication use during pregnancy in a large diverse cohort. We identified women aged 15-45 years who delivered a live born infant between 2001 and 2007 across 11 U.S. health plans within the Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP). Using health plans' administrative and claims data, and birth certificate data, we identified deliveries for which women filled asthma medications from 90 days before pregnancy through delivery. Prevalence (%) was calculated for asthma diagnosis and medication dispensing. There were 586,276 infants from 575,632 eligible deliveries in the MEPREP cohort. Asthma prevalence among mothers was 6.7 %, increasing from 5.5 % in 2001 to 7.8 % in 2007. A total of 9.7 % (n = 55,914) of women were dispensed asthma medications during pregnancy. The overall prevalence of maintenance-only medication, rescue-only medication, and combined maintenance and rescue medication was 0.6, 6.7, and 2.4 % respectively. The prevalence of maintenance-only use doubled during the study period from 0.4 to 0.8 %, while rescue-only use decreased from 7.4 to 5.8 %. In this large population-based pregnancy cohort, the prevalence of asthma diagnoses increased over time. The dispensing of maintenance-only medication increased over time, while rescue-only medication dispensing decreased over time.

KW - Asthma

KW - Medication

KW - Pregnancy

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=84889098032&partnerID=8YFLogxK

U2 - 10.1007/s10995-012-1173-x

DO - 10.1007/s10995-012-1173-x

M3 - Article

VL - 17

SP - 1611

EP - 1621

JO - Maternal and Child Health Journal

JF - Maternal and Child Health Journal

SN - 1092-7875

IS - 9

ER -